SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Summit Technology (BEAM)
BEAM 29.00-5.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: majormember who wrote (1115)3/25/1999 3:09:00 AM
From: Jim Mac  Read Replies (2) of 1386
 
ATCI deal in April will kill Q2 earnings.

And note how Summit's equipment sales stagnated Q3-Q4, along with fees and service revs.

Assuming Summit lasers did 10K more procedures Q4-Q1, that'll drop another $2M+ to bottom line, putting Q1 earnings at about $4M+, or EPS $0.13+.
(For clean Q4 earnings, look at operating income plus interest income.)

But ATCI deal will involve issuing 5M shares of BEAM stock assuming BEAM is at $10 by then, putting total outstanding at 36M+. Read the deal terms at ATCI website.

Then, in Q2, with ATCI's $5M quarterly loss factored in, Summit will B/E or lose money, even with more sequential procedure growth.

Q3 may be $0.05 to $0.10, assuming another $2M hits bottom line after Q2.

So, 1999 *untaxed* EPS looks like $0.28 to $0.38:

Q1/Q2/Q3/Q4: $0.13/0.00/0.05-0.10/0.10-0.15 = $0.28 to $0.38 TOPS.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext